{
    "nctId": "NCT05715255",
    "briefTitle": "Adaptive Symptom Self-Management Immunotherapy Study",
    "officialTitle": "Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Colon Cancer, Lung Cancer, Skin Cancer, Rectum Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 400,
    "primaryOutcomeMeasure": "Change in patient reported psychological distress in Interviews.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 18 or older\n* Within 12 weeks after starting ICI treatment for cancer\n* Cognitively oriented to person, place and time (determined by recruiter)\n* Able to speak and understand English or Spanish\n* Access to a telephone\n* Severity score of 1 (mild) or higher on at least 1 of the 3 indicators of psychological distress from the PRO-CTCAE (i.e., the three items of anxious, discouraged, sad) library\n\nExclusion Criteria:\n\n* Currently receiving regular behavioral counseling",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}